Skip to content

Water washing after electrocoagulation during Endoscopic submucosal dissection for colorectal neoplasm in the prevention of Electrocoagulation Syndrome: A Prospective, Multi-Center, Randomized, Clinical Trial

Water washing after electrocoagulation during Endoscopic submucosal dissection for colorectal neoplasm in the prevention of Electrocoagulation Syndrome: A Prospective, Multi-Center, Randomized, Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064741
Enrollment
Unknown
Registered
2022-10-15
Start date
2022-10-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastrointestinal cancer

Interventions

Test:water washing
Conrol group:Standard ESD

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age>18 years old and < 80 years; 2. Normal preoperative body temperature; 3. Preoperative colonoscopy or endoscopic ultrasound assessment is suitable for patients undergoing ESD; 4. Endoscopic examination of mucosal lesions with a size greater than or equal to 2cm; 5. There is no concomitant organic disease of the colon and rectum; 6. Single ESD resection of a single lesion; 7. Patients or family members who understand the research protocol and are willing to participate in this study provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Under the microscope, it is determined to be a pedunculated polyp; 2. Circumferential lesions; 3. Individuals with low immunity or those undergoing immunosuppressive therapy; 4. Patients with concurrent organic colorectal diseases and intestinal diseases; 5. Patients with familial polyposis; 6. Patients with a history of previous colorectal surgery that may affect the outcome of this surgery; 7. Pregnant or lactating women: 8. Patients with severe emphysema, interstitial pneumonia, or ischemic heart disease who cannot tolerate anesthesia and surgery; 9. The patient has contraindications for ESD surgery; 10. Patients or family members are unable to understand the conditions and objectives of this study.

Design outcomes

Primary

MeasureTime frame
PEECS;

Secondary

MeasureTime frame
Incidence of postoperative bleeding perforation;VAS score;Postoperative laboratory examination;Postoperative hospital stay;Postoperative maximum body temperature;

Countries

China

Contacts

Public ContactZhong Yunshi

Zhongshan Hospital, Fudan University

zhong.yunshi@zs-hospital.sh.cn+86 13564623481

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026